nigericin has been researched along with Gout in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, SY; He, XH; Li, YP; Liang, QQ; Ou-Yang, DY; Shi, ZJ; Xu, LH; Xu, R; You, YP; Yuan, T; Zha, QB; Zhang, HR | 1 |
| Avouac, J; Bennana, E; Chiocchia, G; Devauchelle, V; Ea, HK; Gonzalez, V; Gottenberg, JE; Guillonneau, F; Mistou, S; Mouasni, S; Schmitt, A; Tourneur, L | 1 |
2 other study(ies) available for nigericin and Gout
| Article | Year |
|---|---|
Theaflavin mitigates acute gouty peritonitis and septic organ injury in mice by suppressing NLRP3 inflammasome assembly.
Topics: Adenosine Triphosphate; Animals; Antioxidants; Caspases; Gout; Inflammasomes; Interleukin-1beta; Mice; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Peritonitis; Reactive Oxygen Species; Sepsis | 2023 |
The classical NLRP3 inflammasome controls FADD unconventional secretion through microvesicle shedding.
Topics: Animals; Arthritis, Rheumatoid; Caspase 1; Cell Line, Tumor; Cell-Derived Microparticles; Fas-Associated Death Domain Protein; Gout; Humans; Immunity, Innate; Inflammasomes; Inflammation; Interleukin-1beta; Macrophages; Monocytes; Nigericin; NLR Family, Pyrin Domain-Containing 3 Protein; Potassium Channels; Pyroptosis | 2019 |